沉淀作为早期口服药物吸收预测的关键参数,第一部分:关键数据的获取。

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Sara Mayer , Christian Wagner , Andreas Lehmann , Zhizhou Fang , Werner Weitschies , Katharina Krollik
{"title":"沉淀作为早期口服药物吸收预测的关键参数,第一部分:关键数据的获取。","authors":"Sara Mayer ,&nbsp;Christian Wagner ,&nbsp;Andreas Lehmann ,&nbsp;Zhizhou Fang ,&nbsp;Werner Weitschies ,&nbsp;Katharina Krollik","doi":"10.1016/j.ejps.2025.107210","DOIUrl":null,"url":null,"abstract":"<div><div>Despite recent advancements in the development of in vitro precipitation assays for weakly basic drugs, their relevance for predicting in vivo oral absorption remains ambiguous, highlighting the need for further research. The objective of this study was to develop a predictive tool for drug absorption of basic drugs, grounded in data derived from in vitro solubility, permeability, and precipitation assays which is particularly suited for application in drug discovery. The study aimed to compile a comprehensive dataset comprising in vitro solubility, permeability, and precipitation data, and in vivo absorption data for a set of 17 model compounds. The dataset was designed to serve as foundation for the development of an absorption prediction tool specifically tailored for drug discovery. For this purpose, solubility and permeability data were measured using a consistent experimental set-up for each, ensuring data comparability. Furthermore, a miniaturized precipitation assay (µPA) was developed that enables streamlined screening of drug candidates, thereby enhancing the lead optimization process during drug discovery. In vivo absorption data for the 17 model compounds were gathered through a comprehensive literature review, addressing the inherent challenges associated with acquiring high-quality in vivo absorption data. The results of this study indicate a decent relationship between the extent of precipitation in vitro, and the fraction of a drug absorbed in vivo. In-depth statistical analysis of the dataset and the development of the absorption prediction tool will be described in a subsequent publication.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"213 ","pages":"Article 107210"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Precipitation as key parameter for early oral drug absorption predictions, Part I: Acquisition of critical data\",\"authors\":\"Sara Mayer ,&nbsp;Christian Wagner ,&nbsp;Andreas Lehmann ,&nbsp;Zhizhou Fang ,&nbsp;Werner Weitschies ,&nbsp;Katharina Krollik\",\"doi\":\"10.1016/j.ejps.2025.107210\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Despite recent advancements in the development of in vitro precipitation assays for weakly basic drugs, their relevance for predicting in vivo oral absorption remains ambiguous, highlighting the need for further research. The objective of this study was to develop a predictive tool for drug absorption of basic drugs, grounded in data derived from in vitro solubility, permeability, and precipitation assays which is particularly suited for application in drug discovery. The study aimed to compile a comprehensive dataset comprising in vitro solubility, permeability, and precipitation data, and in vivo absorption data for a set of 17 model compounds. The dataset was designed to serve as foundation for the development of an absorption prediction tool specifically tailored for drug discovery. For this purpose, solubility and permeability data were measured using a consistent experimental set-up for each, ensuring data comparability. Furthermore, a miniaturized precipitation assay (µPA) was developed that enables streamlined screening of drug candidates, thereby enhancing the lead optimization process during drug discovery. In vivo absorption data for the 17 model compounds were gathered through a comprehensive literature review, addressing the inherent challenges associated with acquiring high-quality in vivo absorption data. The results of this study indicate a decent relationship between the extent of precipitation in vitro, and the fraction of a drug absorbed in vivo. In-depth statistical analysis of the dataset and the development of the absorption prediction tool will be described in a subsequent publication.</div></div>\",\"PeriodicalId\":12018,\"journal\":{\"name\":\"European Journal of Pharmaceutical Sciences\",\"volume\":\"213 \",\"pages\":\"Article 107210\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-07-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S092809872500209X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S092809872500209X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

尽管弱碱性药物的体外沉淀测定法最近取得了进展,但它们与预测体内口服吸收的相关性仍然不明确,这突出了进一步研究的必要性。本研究的目的是开发一种预测基本药物吸收的工具,该工具基于体外溶解度、渗透性和沉淀测定的数据,特别适合于药物发现的应用。该研究旨在编制一个全面的数据集,包括17种模型化合物的体外溶解度、渗透性、沉淀数据和体内吸收数据。该数据集旨在作为开发专门为药物发现量身定制的吸收预测工具的基础。为此,使用一致的实验设置测量溶解度和渗透率数据,以确保数据的可比性。此外,开发了微尺度沉淀测定法(µPA),可以简化候选药物的筛选,从而增强药物发现过程中的先导物优化过程。通过全面的文献综述,收集了17种模型化合物的体内吸收数据,解决了与获得高质量体内吸收数据相关的固有挑战。本研究结果表明,体外沉淀程度与体内吸收药物的比例之间存在良好的关系。对数据集的深入统计分析和吸收预测工具的开发将在随后的出版物中描述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Precipitation as key parameter for early oral drug absorption predictions, Part I: Acquisition of critical data

Precipitation as key parameter for early oral drug absorption predictions, Part I: Acquisition of critical data
Despite recent advancements in the development of in vitro precipitation assays for weakly basic drugs, their relevance for predicting in vivo oral absorption remains ambiguous, highlighting the need for further research. The objective of this study was to develop a predictive tool for drug absorption of basic drugs, grounded in data derived from in vitro solubility, permeability, and precipitation assays which is particularly suited for application in drug discovery. The study aimed to compile a comprehensive dataset comprising in vitro solubility, permeability, and precipitation data, and in vivo absorption data for a set of 17 model compounds. The dataset was designed to serve as foundation for the development of an absorption prediction tool specifically tailored for drug discovery. For this purpose, solubility and permeability data were measured using a consistent experimental set-up for each, ensuring data comparability. Furthermore, a miniaturized precipitation assay (µPA) was developed that enables streamlined screening of drug candidates, thereby enhancing the lead optimization process during drug discovery. In vivo absorption data for the 17 model compounds were gathered through a comprehensive literature review, addressing the inherent challenges associated with acquiring high-quality in vivo absorption data. The results of this study indicate a decent relationship between the extent of precipitation in vitro, and the fraction of a drug absorbed in vivo. In-depth statistical analysis of the dataset and the development of the absorption prediction tool will be described in a subsequent publication.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.60
自引率
2.20%
发文量
248
审稿时长
50 days
期刊介绍: The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信